Evidence map›Paper›PMID 39140751›Full record

ReviewJournal of bacteriology2024

Hitchhiker's Guide to

Jeffrey S Bourgeois, Linden T Hu

Abstract readReview
In one paragraph

Review in Journal of bacteriology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Protective efficacy of mutant strains ofInfection and immunity · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Mechanisms of bacterial host-to-host transmission.Microbiology and molecular biology reviews : MMBR · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jeffrey S BourgeoisDepartment of Molecular Biology and Microbiology, Tufts University Lyme Disease Initiative, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0001-9037-8418
Linden T HuDepartment of Molecular Biology and Microbiology, Tufts University Lyme Disease Initiative, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0003-1659-5558

Funding

Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferiR01AI152210 · NIAID · TUFTS UNIVERSITY BOSTON · PI HU, LINDEN T, LEWIS, KIM · 2020 to 2025
$3.9M
Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferiR01AI150157 · NIAID · TUFTS UNIVERSITY BOSTON · PI HU, LINDEN T · 2020 to 2024
$3.0M
Auto-antibodies as predictive markers for Post treatment Lyme Disease SyndromeR01AI178725 · NIAID · TUFTS UNIVERSITY BOSTON · PI Linden T Hu · 2023 to 2026
$2.5M
Identifying Determinants of Borrelia burgdorferi and Peromyscus leucopus symbiosisF32AI179104 · NIAID · TUFTS UNIVERSITY BOSTON · PI BOURGEOIS, JEFFREY · 2023 to 2025
$143k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) F32AI179104HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI152210, R01AI150157, R01AI178725NIAID NIH HHS F32 AI179104NIAID NIH HHS R01 AI150157NIAID NIH HHS R01 AI152210NIAID NIH HHS R01 AI178725
6 · The paper itself

Abstract

Don't Panic. In the nearly 50 years since the discovery of Lyme disease,

Indexed as

Borrelia burgdorferiLyme DiseaseAnimalsHost-Pathogen InteractionsHumansTicksBorreliaBorrelia burgdorferiBorreliella burgdorferigeneticshistoryhost-pathogen interactionsimmunologyLyme diseasespirochetes

Identifiers

PMID39140751
PMCPMC11411949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.